| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | -0.097 | 0.1 |
| mRNA | 16-beta-bromoandrosterone | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | 0.076 | 0.1 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | Methotrexate | FIMM | pan-cancer | AAC | -0.22 | 0.1 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |